Pharmacy retailer Dis-Chem saw double-digit headline earnings growth and upped its dividend, but rising operational costs grew at a faster rate than its revenue growth in its year to end-February.
Excluding Covid-19 vaccines, its revenue growth increased 9%, with wholesale revenue from its medicine distribution business up 10.4% to R24.2bn...A subscription helps you enjoy the best of our business content every day along with benefits such as articles from our international business news partners; ProfileData financial data; and digital access to the Sunday Times and TimesLive Premium.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: